340B Drug Pricing Program Contributes to Rising Healthcare Costs and Is Ripe for Reform
The U.S. House Energy & Commerce Committee's Health Subcommittee today will host the third hearing in its health care affordability series, specifically examining the role providers and hospitals play in shaping the cost of care for Americans.
While the hearing will likely examine numerous issues, there is none more ripe for reform than the flawed 340B drug pricing program.
Originally enacted to help eligible safety-net providers buy medicines at steep discounts and pass the savings on to lower-income and vulnerable patients, the program has ballooned as a revenue stream for many participating hospitals and contract pharmacy chains.
As the size and complexity of the 340B program has expanded, participating hospitals and contract pharmacies have instead used the program to increase…[more]
Three years into the Biden presidency, the federal government’s estimated annualized interest payments on the national debt now exceed $1 trillion.
For purposes of comparison, the Biden Administration requested just $773 billion for the Department of Defense for 2023.
That worrisome development isn’t bad luck or coincidence. It’s a direct consequence of Biden’s policy choices since entering office.
Specifically, Biden campaigned in 2020 on a soothing theme of restoring normalcy and moderation to the nation. In office, however…
